As such, we selected RP11-334A14.8, RP4-738P11.4, LINC00668, and LINC00941, which showed higher expression in the relapsed tumor group than in the primary tumor group for qRT-PCR validation. This evidence concerns the gene LINC00941 and neoplasm.